What impact can we expect from the abolition of NHS England (NHSE) and changes at the Department of Health and Social Care (DHSC)? What do these changes mean for your...
Read More
What does the abolition of NHS England mean for your market access and NHS Engagement strategy? How will the changes at national and integrated care board (ICB) level impact launch...
Read More
In June 2024, we joined Petauri, a purpose-built pharmaceutical services platform combining best-in-class companies with recognised expertise in global market access, medical affairs, patient services, and data and analytics. As part...
Read More
Today, Prime Minister Sir Keir Starmer announced the abolition of NHS England. Here we reflect on the implications for the Pharma industry.
What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging...
Read More
Discover how health economics can support successful Medical Device launch, proposition development, and market access This webinar offers an insightful journey into the world of medical device market access. Specialists...
Read More
Discover our top picks for must-attend sessions at the World EPA Congress 2025 in Amsterdam. Enhance your understanding of core topics with our recommended pre-reading materials
Discover Sophie Streeton’s career journey and her decision to join Mtech Access. Learn about her early experiences in the Global Market Access Team. Sophie leverages her expertise in health policy, medical writing, and market access.
We are delighted to announce that Clare Foy (Director – Global Market Access), Hannah Palin (Director – Local Market Access), and Calum Jones (Associate Director – Health Economics) will be...
Read More
Global healthcare faces growing pressures. We explore how HEOR is evolving in 2025 to deliver value, meet payer needs, and support market access decisions.
